In episode 25 of “The Conversational Flow” podcast, guest David Leclerc, Director of the Cytometry and Antibody Technology (CAT) Facility at the University of Chicago, joins Brian and Adam to share his professional journey and insights into the evolving world of flow cytometry. Leclerc reflects on his early struggles during…
As an emerging and growing application, spectral flow cytometry offers capabilities beyond what is possible with conventional flow. Its unique capabilities make it a powerful tool for scientists aiming to extract more information from each sample and push the boundaries of discovery. Join us in this post as we…
In this episode, Adam and Brian explored recent advances in cell sorting technology, focusing on image-activated approaches. Unlike traditional flow cytometry, which relies on voltage signals, these systems capture and analyze cell images in real time to guide sorting decisions, enabling new insights such as subcellular localization and cell-to-cell signaling.
What is immunogenicity? Immunogenicity refers to the ability of a substance, such as a New Biological Entity (NBE) or a vaccine, to provoke an immune response when administered in the body. The recognition of the substance as foreign triggers an immune response, which involves the production of antibodies and the…
Why Sample Matrix Choice Matters Choosing the right sample matrix is one of the most critical decisions when designing a flow cytometry assay. Each option offers unique advantages and limitations that can directly impact data quality, logistics, and study outcomes. Flow cytometry requires intact, viable cells. The power of flow…
November 5
- November 5
Please join us for an exclusive, behind-the-scenes look at KCAS Bio. This private event is specifically for our most valued sponsors to engage directly with our scientists and explore our capabilities. Wednesday, November 5, 2025 | 4:00pm – 6:00pm 4:00 – 4:30pm | Welcome & Introduction 4:30 – 5:00pm…
In episode #23 of The Conversational Flow, Adam and Brian tackle the question: When can flow cytometry be applied to non-blood matrices, and what must be considered? Using sputum analysis as a case study, they outline the challenges of clinical trial sample collection, emphasizing the importance of pre-analytical factors like…
If you’ve worked in drug development, you already know that the road from discovery to clinical success is long, expensive, and rarely linear. One of the most pivotal checkpoints in that journey is cytotoxicity testing. Whether you’re developing a small molecule, a biologic, or a cell therapy like CAR‑T, the…
In this episode, the hosts introduce Karla Moncada, who shares her professional journey from Flowcore management to her current role at KCAS Bio, and unveils her new KCAS Bio video series, Karla’s Corner, aimed at fostering year-round conversations within the flow cytometry community. Karla emphasizes the value of personal connections…
KCAS Bio will be attending the NCCG Annual Meeting 2025, taking place in San Francisco on September 22. This gathering, hosted by NorCal Cytometry Group, unites professionals across the scientific, regulatory, and biotech communities who are interested in the advancements in the field of flow cytometry. The annual meeting will…
KCAS Bio will be attending MetroFlow 2025 Annual Meeting, taking place October 23 in New York, NY. The MetroFlow 2025 Annual Meeting brings together a dedicated community of flow cytometry professionals, including core facility directors, technical experts, researchers, and service providers. As such, this gathering provides a collaborative environment to…
KCAS Bio will be attending the International Clinical Cytometry Society (ICCS) meeting 2025 on September 26-30 in Philadelphia, PA. This annual meeting brings together leaders and scientists to advance the understanding and application of technologies and methodologies in patient sample analysis. Through presentations and collaborative discussions, attendees will explore the…